Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Other Non Operating Income (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Other Non Operating Income data on record, last reported at -$71000.0 in Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 30.39% year-over-year to -$71000.0; the TTM value through Dec 2025 reached -$456000.0, down 46.15%, while the annual FY2025 figure was -$456000.0, 46.15% down from the prior year.
  • Other Non Operating Income reached -$71000.0 in Q4 2025 per TLSI's latest filing, up from -$94000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $639000.0 in Q4 2023 and bottomed at -$3.4 million in Q2 2023.
  • Average Other Non Operating Income over 4 years is -$321692.3, with a median of -$71000.0 recorded in 2025.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 98.72% in 2024, then plummeted 623.08% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at -$31000.0 in 2022, then skyrocketed by 2161.29% to $639000.0 in 2023, then plummeted by 115.96% to -$102000.0 in 2024, then soared by 30.39% to -$71000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were -$71000.0 in Q4 2025, -$94000.0 in Q3 2025, and -$40000.0 in Q2 2025.